New Zealand markets closed

Clover Biopharmaceuticals, Ltd. (2197.HK)

HKSE - HKSE Delayed price. Currency in HKD
Add to watchlist
0.380+0.010 (+2.70%)
At close: 04:08PM HKT
Show:
Income statement
Balance sheet
Annual

Cash flow

Currency in CNY. All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
31/12/2019
Cash flows from operating activities
Net income
-138,539
-138,539
-2,451,903
-6,016,303
-912,898
-
Depreciation & amortisation
74,742
74,742
60,094
25,389
5,784
-
Stock-based compensation
53,515
53,515
95,023
125,214
0
-
Change in working capital
-2,493,865
-2,493,865
56,634
1,076,988
751,507
-
Inventory
-8,697
-8,697
-2,090,396
-771,754
-50,488
-
Other working capital
-737,054
-737,054
-1,796,369
-998,065
363,135
-
Other non-cash items
2,605
2,605
-2,577
3,804,964
597,224
-
Net cash provided by operating activities
-727,878
-727,878
-1,690,809
-917,749
476,927
-
Cash flows from investing activities
Investments in property, plant and equipment
-9,176
-9,176
-105,560
-80,316
-113,792
-
Purchases of investments
0
0
-13,929
-30,000
-280,328
-
Sales/maturities of investments
3,015
3,015
79,782
222,440
-
-
Net cash used for investing activities
-6,161
-6,161
-37,506
112,124
-394,120
-
Net change in cash
-876,447
-876,447
-1,245,172
2,251,548
399,654
-
Cash at beginning of period
1,607,409
1,607,409
2,767,371
516,184
148,694
-
Cash at end of period
735,864
735,864
1,607,409
2,767,371
516,184
-
Free cash flow
Operating cash flow
-727,878
-727,878
-1,690,809
-917,749
476,927
-
Capital expenditure
-9,176
-9,176
-105,560
-80,316
-113,792
-
Free cash flow
-737,054
-737,054
-1,796,369
-998,065
363,135
-